Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD
Ruben Poesen(KU Leuven), Björn Meijers(VIB-KU Leuven Center for Microbiology), Kathleen Claes(KU Leuven), Patrick Augustijns(KU Leuven), Pieter Evenepoel(KU Leuven), Dirk Kuypers(KU Leuven), Henriëtte de Loor
Cited by 217
Related Papers
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
Uremic toxins originating from colonic microbial metabolism
|Kidney International|2009|442
Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target
|American Journal of Kidney Diseases|2015|387